The extract of Serenoa repens in the treatment of benign prostatic hyperplasia: A multicenter open study
- 1 July 1994
- journal article
- Published by Elsevier in Current Therapeutic Research
- Vol. 55 (7) , 776-785
- https://doi.org/10.1016/s0011-393x(05)80771-4
Abstract
No abstract availableThis publication has 17 references indexed in Scilit:
- Comparison of finasteride (proscar®), a 5α reductase inhibitor, and various commercial plant extracts in in vitro and in vivo 5α reductase inhibitionThe Prostate, 1993
- The American Urological Association Symptom Index for Benign Prostatic HyperplasiaJournal of Urology, 1992
- Determination of Prostate Volume by Transrectal UltrasoundJournal of Urology, 1991
- The Efficacy of Transurethral Resection of the Prostate in Men with Moderate Symptoms of ProstatismJournal of Urology, 1990
- Transurethral Prostatectomy: Immediate and Postoperative Complications. A Cooperative Study of 13 Participating Institutions Evaluating 3,885 PatientsJournal of Urology, 1989
- Use of Claims Data Systems to Evaluate Health Care OutcomesJAMA, 1987
- A double‐blind trial of an extract of the plant Serenoa repens in benign prostatic hyperplasia.British Journal of Clinical Pharmacology, 1984
- Inhibition of androgen metabolism and binding by a liposterolic extract of “serenoa repens B” in human foreskin fibroblastsJournal of Steroid Biochemistry, 1984
- Changes in the Metabolism of Dihydrotestosterone in the Hyperplastic Human Prostate*Journal of Clinical Endocrinology & Metabolism, 1983
- Origin of Estrogen in Normal Men and in Women with Testicular Feminization*Journal of Clinical Endocrinology & Metabolism, 1979